Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Detection of disseminated tumor cells in bone marrow predict late recurrences in operable breast cancer patients

Fig. 3

Survival analyses according to disseminated tumor cell (DTC) detection in bone marrow (BM) samples obtained prior to surgery (a and b, n = 156) and 3 weeks and/or 6 months after surgery (c and d, n = 126) from operable breast cancer patients who did not experience disease recurrence or died during the first 5 years after surgery. Median follow-up was 15.3 years, but the first 5 years were subtracted from all survival times prior to analysis

Back to article page